financetom
Business
financetom
/
Business
/
Sanofi to Invest $1.08 Billion Into 3 French Drug Manufacturing Sites
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Sanofi to Invest $1.08 Billion Into 3 French Drug Manufacturing Sites
May 13, 2024 4:59 AM

07:42 AM EDT, 05/13/2024 (MT Newswires) -- Sanofi ( SNY ) said Monday it will invest more than 1 billion euros ($1.08 billion) into three French drug manufacturing facilities as it ramps up production in its home country.

Price: 49.66, Change: +0.38, Percent Change: +0.77

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sector Update: Consumer
Sector Update: Consumer
Jul 1, 2024
08:50 AM EDT, 07/01/2024 (MT Newswires) -- Consumer stocks were mixed premarket Monday with the Consumer Staples Select Sector SPDR Fund (XLP) down 0.1% and the Consumer Discretionary Select Sector SPDR Fund (XLY) 0.4% higher recently. Chewy (CHWY) rose nearly 12% after Keith Gill, the stock influencer known as Roaring Kitty, disclosed a 6.6% stake in the company. ...
EHang, China Southern Airlines Unit Partner to Support Low-Altitude Flight Services
EHang, China Southern Airlines Unit Partner to Support Low-Altitude Flight Services
Jul 1, 2024
08:45 AM EDT, 07/01/2024 (MT Newswires) -- EHang Holdings ( EH ) , a Chinese drone maker, said Monday that it has signed a memorandum of understanding with a China Southern Airlines unit to provide support for low-altitude flight services. EHang ( EH ) said its partnership with China Southern Airlines General Aviation will focus on the flight operations, support...
AbbVie Says Robert Michael Assumes CEO Role
AbbVie Says Robert Michael Assumes CEO Role
Jul 1, 2024
08:51 AM EDT, 07/01/2024 (MT Newswires) -- AbbVie ( ABBV ) said Monday that Robert Michael has assumed the role of chief executive of the company and become a board member. Michael previously served as president and chief operating officer. AbbVie ( ABBV ) announced in February that Michael would succeed Richard Gonzalez as CEO. Gonzalez has become executive chairman...
Humacyte's ATEV Treatment Gets New FDA Designation; Shares Rise Pre-Bell
Humacyte's ATEV Treatment Gets New FDA Designation; Shares Rise Pre-Bell
Jul 1, 2024
08:45 AM EDT, 07/01/2024 (MT Newswires) -- Humacyte ( HUMA ) said Monday its investigational Acellular Tissue Engineered Vessel, or ATEV, was granted the US Food and Drug Administration's Regenerative Medicine Advanced Therapy designation for patients with advanced peripheral artery disease. The designation will grant the company priority in consultations with the FDA regarding ATEV and potentially expedite future license...
Copyright 2023-2026 - www.financetom.com All Rights Reserved